http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI0614090-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-165 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-498 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4965 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4045 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165 |
| filingDate | 2006-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9426d687de798357c3b9a66f4f7007d9 |
| publicationDate | 2011-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | BR-PI0614090-A2 |
| titleOfInvention | use of hdac inhibitors for the treatment of myeloma |
| abstract | Use of HDAC Inhibitors for Myeloma Treatment. The present invention relates to the use of an HDAC inhibitor, especially an HDAC inhibitor of formula (1), wherein the radicals and symbols have the meanings as defined in the report for the preparation of a medicament for the treatment of myeloma. , in particular multiple myeloma, especially conventional chemotherapy resistant myeloma; a combination comprising an HDAC inhibitor and an apoptosis compound of myeloma cells, preferably bortezomib, for simultaneous, separate or sequential use; methods of treating myeloma; and to a pharmaceutical composition comprising said combination. |
| priorityDate | 2005-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 215.